Ischemic preconditioning (IP) exerts cardioprotection through protein kinase C (PKC) activation, whereas myocardial ischemia enhances vascular endothelial growth factor (VEGF) mRNA expression. However, the IP effect or the involvement of PKC on the VEGF expression is unknown in myocardial infarction. We investigated whether IP enhances VEGF gene expression and angiogenesis through PKC activation in the in vivo myocardial infarction model. Sprague-Dawley rats were assigned into the following 3 groups: the sham group; the IP group, which underwent 3 cycles of 3 minutes of ischemia and 5 minutes of reperfusion (IP procedure); and the non-IP group. The latter 2 groups were subsequently subjected to left anterior descending coronary artery occlusion. To examine the involvement of PKC, the PKC inhibitor chelerythrine (5 mg/kg) or bisindolylmaleimide (1 mg/kg) was injected intravenously before the IP procedures. PKC⑀ was translocated to the nucleus after 10 minutes of ischemia after the IP procedure but was not translocated in the non-IP and the sham groups. VEGF mRNA expression 3 hours after infarction was significantly higher in the IP group than in the non-IP and the sham groups. Capillary density in the infarction was significantly higher, whereas the infarct size was smaller in the IP group than in the non-IP group at 3 days of infarction. Chelerythrine but not bisindolylmaleimide blocked all of the IP effects on the nuclear translocation of PKC⑀, enhancement of VEGF mRNA expression and angiogenesis, and infarct size limitation. These results show that IP may enhance VEGF gene expression and angiogenesis through nuclear translocation of PKC⑀ in the infarcted myocardium. (Circ Res. 2001;88:696-704.)
N eovascularization is induced both under physiological conditions such as wound healing and maturation of ovarian follicles and under pathological conditions including tumor, rheumatoid arthritis, and retinopathies. 1, 2 Neovascularization also plays a pivotal role in the remodeling of cardiac tissue after ischemia and infarction. 3, 4 Vascular endothelial growth factor (VEGF), an angiogenic mitogen, is a highly specific growth factor for vascular endothelial cells both in vitro and in vivo. 5, 6 VEGF mRNA is induced by hypoxia in cultured cells. 7, 8 Previous studies showed that transient ischemia upregulates VEGF mRNA in cardiac tissues, suggesting that VEGF mediates neovascularization during myocardial ischemia. 8, 9 It is well known that repetitive transient ischemiareperfusion confers the protective effect, referred to as ische-mic preconditioning (IP), on the myocardium against subsequent prolonged ischemia. 10 -12 The protection resulting from IP is manifested as a reduction in infarct size, decreased incidence of arrhythmias, and improved postischemic contractile dysfunction. 12, 13 Many studies showed that the effects of IP are mediated by protein kinase C (PKC). 11, 12, 14 Among Ͼ10 PKC isoforms, we showed that PKC␣, -␦, -⑀, andisoforms are expressed in rat myocardium. 15, 16 We showed that either PKC␦ or PKC⑀ is required for the protective effect of IP in the isolated rat heart. 17, 18 More recent studies indicated that the PKC⑀ isoform especially plays a pivotal role in the cardioprotection conferred by IP. 14, 19 Although PKC activation is important in IP, the role of each PKC isoform has not been fully elucidated except for the link between PKC␣ and ecto-5Ј-nucleotidase. 12, 20 Although im- Figure 1 . A, Representative Western blots indicating distribution of PKC isoforms in sham-operated hearts and in hearts rendered ischemic for 10 minutes after IP or non-IP procedure. B, Effect of IP on PKC isoform redistribution in subcellular fractions. Isoform contents, quantified from Western blots, are expressed as percentage of mean value of the sham group (100%). ****PϽ0.001 vs sham group, † † †PϽ0.005 vs non-IP group. A and B, P1 indicates nucleus plus myofibril fraction; P2, membrane fraction; and S, cytosol fraction. C, Immunohistochemical staining for PKC⑀ in the ischemic area of the non-IP group (a) and the IP group (b) after 10 minutes of ischemia after IP procedure. IP induced nuclear translocation of PKC⑀ in the cardiomyocytes.
plications for the effect of IP were not sought, a recent paper shows the binding of PKC⑀ to 36 proteins such as signaling molecules, structural proteins, and stress-activated proteins in the heart. 21 The activation of PKC also plays a key role in the intracellular signaling pathway for cellular growth. 22 It has been shown that PKC is involved in the growth of endothelial cells during angiogenesis 23 and that VEGF requires PKC activation for its angiogenic effect. 24, 25 On the other hand, hypoxia-inducible factor-1␣ (HIF-1␣), a transcription factor, is induced by hypoxia and activates genes related to angiogenesis including VEGF, erythropoietin, and endothelin-1. 26, 27 Previous study showed that HIF-1␣ is induced transiently in the ischemic or infarcted myocardium, followed by upregulation of the VEGF gene. 28 However, it is not known in the heart whether PKC or HIF-1␣ lies upstream of the signaling pathway of the VEGF-mediated angiogenesis both in vivo and in vitro.
Our clinical studies showed that the serum levels of VEGF were significantly higher in patients with acute myocardial infarction (AMI) than in those without 29 and that the level was higher in the AMI patients with preinfarction angina than in those without. 30 These findings led us to hypothesize that IP increases VEGF level through PKC activation, thereby increasing capillary density through the induction of the VEGF gene in the course of AMI. In this study, we sought to test this hypothesis in the rat model of AMI.
Materials and Methods

Materials
Male Sprague-Dawley rats age 8 weeks (nϭ239) (SLC Japan, Shizuoka, Japan) were anesthetized with sodium pentobarbital (50 mg/kg, IP). The experimental protocol was approved by the University of Tokyo and Nara Medical University committees on animal experiments.
Surgical Procedure
The left anterior descending coronary artery (LAD) was ligated as previously described. 9 In the IP group, the ligature was released for 5 minutes after LAD ligation for 3 minutes (3-minute ischemia and 5-minute reperfusion), and after 3 cycles of this procedure (IP procedure), the LAD was reoccluded to induce infarction. In the non-IP group, the rats underwent the LAD ligation for infarction after a 24-minute nonischemic period without the IP procedure. The rats in the sham group underwent the same procedure except for the LAD ligation. 
PKC Isoform Distribution
To localize PKC isoforms in the ischemic area, 10 minutes after the surgical procedures, Western blotting of the subcellular fractions (nϭ5) and immunohistochemical staining of the frozen sections (nϭ3) were performed as previously described by use of antibodies to PKC␣, -␦, -⑀, and -(Transduction Laboratories). 15, 17, 18, [31] [32] [33] [34] [35] 
VEGF mRNA Expression
Northern hybridization was performed as previously described 9, 36 to measure the VEGF mRNA levels in the infarcted and the nonischemic tissues after 3 hours of infarction after the IP or the non-IP procedure (nϭ5) and to evaluate the temporal change in the infarcted areas 3, 6, and 12 hours and 1, 2, 3, and 7 days after infarction (nϭ3). The primers for VEGF were the following: sense, 5Ј-CCGAATTCATGAACTTTCTGCT-3Ј, and antisense, 5Ј-GAGGAAGCTTCTTCCTGCCAGC-3Ј. The signals of specific mR-NAs were quantified by use of a bio-imaging analyzer (BAS 5000, Fujix) and were normalized by GAPDH mRNA signals. 9 The VEGF mRNA levels in each cardiac tissue sample from the IP and the non-IP groups were expressed as percentage of the mean value of the sham group (100%). In situ hybridization was also performed on the horizontal sections of the heart sampled 3 hours after infarction (nϭ3) as we previously described. 37 The probes for VEGF were the following: antisense, 5Ј-ATCTCTCCTATGTGCTGGCTTTGGT-GAGGTTTGATCCGCA-3Ј, and sense, 5Ј-TGCGGATCAAACCT CACCAAAGCCAGCACATAGGAGAGAT-3Ј.
HIF-1␣ Expression
Western blotting of the subcellular fractions from the ischemic tissues after 0.5, 1, and 2 hours of ischemia after the IP or non-IP procedure (nϭ3) was performed as previously described by use of antibody to HIF-1␣ (Santa Cruz Biotechnology). 15, 17, 18, [31] [32] [33] [34] [35] 38 
Capillary Density
Immunostaining by use of anti-rat CD31 antibody (PharMingen) was performed as previously described 39 to determine the capillary density in the infarcted areas 1 or 3 days after infarction (nϭ3). We examined the capillary density in the whole infarcted area on the 3 horizontal sections between the point of ligation and the apex under microscopy. The capillaries were recognized as tubular structures positively stained for CD31.
Infarct Size
Infarct size and area at risk 3 days after infarction (nϭ5) were measured as previously described. 4, 40 The infarct size was measured in the 8 horizontal sections between the point of ligation and the apex. The area at risk was recognized as the area demarcated with 0.3% Evans blue dye, whereas the noninfarcted (stained) and infarcted (not stained) areas were determined after incubation with 1% triphenyltetrazolium chloride (Sigma).
PKC Inhibitor Study
Previous studies showed that chelerythrine abolished the myocardial protection initiated by IP 11 and inhibited the activation of PKC⑀ in the heart induced by IP in the isolated heart 17, 18 and in vivo (5 mg/kg). 14 On the other hand, another PKC-specific inhibitor, bisindolylmaleimide, neither inhibited the translocation of PKC⑀ (but did inhibit PKC␣ and -␦) in the isolated rat heart 18 nor suppressed the cardioprotection by IP in the isolated heart 18 or in vivo. 41 The rats were injected intravenously with chelerythrine (5 mg/kg), bisindolyl-maleimide (1 mg/kg) (Sigma), or vehicle (0.5 mL/kg, 50% DMSO in physiological saline) just before the IP procedure before LAD ligation (nϭ90). The sham rats (nϭ13) received the vehicle and underwent the surgical procedure except for LAD occlusion. Parameters for the IP effects were determined as described above. All of the measurements were performed with the observers being blinded to grouping.
Statistical Analysis
Data are presented as meanϮSD. Significance (PՅ0.05) was determined by ANOVA followed by post hoc analysis with the Fisher procedure. Figure 1A shows representative blots indicating the distribution of PKC isoforms in the myocardium rendered ischemic for 10 minutes after the surgical procedure. Figure 1B shows the quantitative data from the blots. The PKC⑀ level in the P1 (nucleus-myofibril) fraction was significantly higher in the IP group than in the non-IP and sham groups, whereas the levels of PKC␣, -␦, and -in the P1 fraction were similar among the 3 groups. IP redistributed PKC⑀ from the cytosol fraction (S in the figure) to the P1 fraction, whereas there was no translocation to the P2 (membrane) fraction in the all groups. Almost all of the PKC was distributed to the extract but not to the residue after Triton X-100 treatment of the P1 fraction (data not shown). We previously reported that the Triton X-100 extract and residue represent the nuclear fraction and the myofibril fraction, respectively. 32, 42 The difference in the translocation of PKC⑀ between the IP and the non-IP groups was not detected immediately after the IP procedure but was evident after 10 minutes of ischemia subsequent to the IP procedure and thereafter (data not shown). Immunohistochemical staining confirmed the nuclear translocation of PKC⑀ in the myocardial cells after IP and ischemia ( Figure  1C) . These results show that IP and ischemia induces specific translocation of PKC⑀ from the cytosol to the nucleus in the myocardium.
Results
PKC Isoform Distribution
IP Upregulates VEGF mRNA
The VEGF mRNA migrated primarily as a 3.9-kb band (Figure 2A ) on the Northern blot, as reported previously. 7, 9 The VEGF mRNA was upregulated in the infarcted but not in the noninfarcted area after 3 hours of LAD occlusion after the IP but not the non-IP procedure (Figures 2A and 2B) . In situ hybridization revealed that VEGF mRNA is upregulated in the infarcted but not in the noninfarcted cardiomyocytes only after the IP procedure, although VEGF mRNA is expressed predominantly in the vascular endothelial cells in the noninfarcted area in all of the groups as well as in the infarcted area without the IP procedure ( Figure 2C) . Figures 2D and 2E show the chronological change of VEGF mRNA expression in the infarcted area. In the IP group, the VEGF mRNA level was rapidly elevated with a peak at 3 hours after infarction, with a significantly higher level at 3 to 12 hours in the IP group than that in the non-IP group. In the non-IP group, VEGF mRNA was more slowly but significantly upregulated, with a peak level at 2 days but without difference between the IP and the non-IP groups at 1 to 3 days after infarction. The maximum levels of the VEGF mRNA expression were Ϸ2-fold higher in the IP group than in the non-IP group. These results suggest that IP upregulates VEGF mRNA expression in the infarcted cardiomyocytes in the early phase of AMI.
Expression of HIF-1␣
HIF-1␣ was similarly induced in the P1 (Figure 3) but not in the cytosol (not shown) fraction of the ischemic heart at all time points examined as compared with the sham heart. There was no difference between the IP and the non-IP groups, suggesting that IP upregulates VEGF gene independently of the HIF-1␣ induction.
IP Increases Capillary Density in the Infarcted Area
We evaluated the capillary density in the infarcted area 1 and 3 days after infarction that followed the IP or the non-IP procedure on the basis of the previous studies showing that capillary growth is induced significantly at 24 to 72 hours after stimulation with growth factors. 4, 43 Figure 4A shows the representative appearances in the immunohistochemical staining of CD31 in the infarcted myocardium of the IP and the non-IP groups. IP enhanced the neovascularization similarly in the periphery (shown in Figure 4A ) and in the core (not shown) of the infarction after 3 days of LAD occlusion. The capillary density in the infarcted area was significantly higher in the IP group 3 days after infarction than in the non-IP groups 1 and 3 days, as well as in the IP group 1 day, after infarction ( Figure 4B ). In further support of neovascularization, there was increased blood flow because anti-albumin immunostaining showed an increased number of tubular structures (data not shown).
IP Reduces Infarct Size
As shown in Figure 4C , IP significantly reduced infarct size, ie, the ratio of infarcted area to left ventricle area (16.2Ϯ4.3% in the IP group versus 23.8Ϯ1.4% in the non-IP group; 32% reduction, PϽ0.01) and the ratio of infarcted area to area at risk (41.1Ϯ5.2% in the IP group versus 52.8Ϯ6.2% in the non-IP group; 22% reduction, PϽ0.05). IP also reduced the ratio of area at risk to left ventricle area, although not significantly (38.0Ϯ5.8% in the IP group versus 46.3Ϯ5.0% in the non-IP group).
PKC Inhibitor Suppresses IP Effects
In the vehicle and bisindolylmaleimide groups, PKC⑀ translocated from the cytosol fraction to the P1 fraction in the heart rendered ischemic for 10 minutes after the IP procedure, whereas in the chelerythrine and sham groups, the translocation of PKC⑀ was not detected. In all of the groups, there was no significant translocation of PKC␣, -␦, and -. Thus, the translo- cation of PKC⑀ induced by IP was inhibited by chelerythrine but not by bisindolylmaleimide ( Figures 5A and 5B) .
Consistent with the data on PKC⑀ translocation, VEGF mRNA upregulation after 3 hours ( Figure 6 ) and angiogenesis ( Figures 7A and 7B ) and infarct size limitation ( Figure  7C ) after 3 days of infarction after IP were inhibited by chelerythrine but not by bisindolylmaleimide. Additionally, HIF-1␣ is not considered to be involved in the effect of IP on VEGF mRNA induction because chelerythrine did not inhibit the HIF-1␣ induction in the myocardium infarcted for 0.5 to 2 hours after the IP procedure ( Figure 8 ).
Taken together, these data show that the PKC inhibitor chelerythrine inhibited the effects of IP on the activation of PKC⑀, the induction of VEGF mRNA, the enhancement of angiogenesis in the infarcted myocardium, and the reduction of the infarct size. Therefore, it is likely that IP translocates PKC⑀ to the nucleus, thereby upregulating VEGF mRNA and the capillary angiogenesis in the infarcted myocardium, resulting in myocardial protection.
Discussion
The major findings of the present study are that IP induced translocation of PKC⑀ isoform to the nucleus and enhanced expression of VEGF mRNA in the infarcted cardiac myocytes, thereby inducing capillary angiogenesis and reducing the infarct size in the in vivo model of rat AMI. Chelerythrine, a selective PKC inhibitor, inhibited all of the effects of IP, supporting the close association between PKC activation, VEGF mRNA upregulation, enhanced angiogenesis, and the infarct size limitation conferred by IP.
Previously, we showed that PKC␦ or -⑀ exerts the protective effect of IP through membrane translocation in the isolated rat heart. 18 Recent studies also showed that PKC⑀ is a key effector in cardiac protection initiated by IP in cultured rat cardiac myocytes and conscious rabbits. 14, 19 Consistent with these studies, the present study demonstrated for the first time that IP translocates PKC⑀ to the nucleus in the in vivo model of myocardial infarction in the rat heart. There are many proposed substrates for PKC in the membrane, such as ATP-sensitive potassium (K ATP ) channel, ␣ 1 adrenoceptor, adenosine receptor, and ecto-5Ј-nucleotidase. 12,20,44 -46 Therefore, the membrane translocation of PKC has been thought to be a fundamental process in the protection conferred by IP at least in the early phase. By contrast, another fundamental finding of this study is that the nuclear translocation of PKC and the upregulation of a gene is involved in the late phase of IP. Consistent with our findings, Ping et al 21 recently showed that PKC⑀ lies in the nuclear and mitochondrial compartments with physical association with many functional proteins.
Hypoxia is a strong inducer of VEGF. 7, 8 Recent studies showed that transient ischemia or hypoxia enhances the expression of VEGF mRNA and that VEGF induces angiogenesis in the ischemic or infarcted heart. 8, 9 Consistent with these findings, the present study showed that IP enhanced the expression of VEGF mRNA in the ischemic cardiac myocytes in addition to vascular endothelial cells, as denoted by in situ hybridization. Furthermore, we found that the capillary density in the infarcted area increased, whereas the infarct size was reduced significantly at 3 days after the onset of AMI preceded by IP, and this neocapillarization and cardioprotection followed the enhanced expression of VEGF mRNA. Consistent with the protective effect of VEGF on ischemic myocardium, Luo et al 47 reported that addition of VEGF to the hyperkalemic cardioplegic solution protected the heart functionally against ischemia-reperfusion injury in the isolated rat heart. Additionally, several lines of evidence support the idea that VEGF contributes to cardioprotection through the induction of angiogenesis. 3, 4 Taken together, it is likely that IP exerts its cardioprotective effect at least in some portion through the angiogenesis induced by VEGF.
HIF-1␣ is involved in the upregulation of VEGF under hypoxia. 26, 28, 48 However, the present study suggests that HIF-1␣ is not involved in the induction of VEGF mRNA by IP because HIF-1␣ was induced by infarction but was independent of IP or PKC inhibition. Consistent with our data, Hossain et al 49 showed that lead induces the VEGF mRNA expression in human astrocytes through a PKCdependent and HIF-1-independent mechanism. Moreover, Shih et al 50 suggested that PKC upregulates VEGF mRNA in the human glioblastoma cell through the stabilization of VEGF mRNA. The temporal change of VEGF mRNA in this study supports the hypothesis in that the IP rapidly and greatly upregulated VEGF mRNA at 3 to 12 hours after infarction, whereas there was a smaller extent of VEGF mRNA induction irrespective of the IP procedure at 1 to 3 days after infarction ( Figures 2D and 2E ). Taken together with the temporal relationship and the correlation by PKC inhibition between the PKC⑀ translocation, VEGF mRNA upregulation, neocapillarization, and infarct limitation, it is quite likely that the nuclear translocation of PKC⑀ plays a pivotal role in the induction of VEGF mRNA in the precon-ditioned rat heart possibly through the stabilization of its mRNA, thereby inducing angiogenesis and cardioprotection.
In conclusion, our data strongly suggest that IP exerts a cardioprotective effect through nuclear translocation of PKC⑀ and VEGF-induced angiogenesis.
